Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CNCE

Concert Pharmaceuticals (CNCE) Stock Price, News & Analysis

Concert Pharmaceuticals logo

About Concert Pharmaceuticals Stock (NASDAQ:CNCE)

Advanced Chart

Key Stats

Today's Range
$8.37
$8.37
50-Day Range
$8.33
$8.40
52-Week Range
$2.66
$8.55
Volume
N/A
Average Volume
2.97 million shs
Market Capitalization
$401.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CNCE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Concert Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CNCE Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

CNCE Stock Analysis - Frequently Asked Questions

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) announced its quarterly earnings data on Tuesday, November, 9th. The biotechnology company reported ($0.78) earnings per share for the quarter, topping analysts' consensus estimates of ($0.81) by $0.03. The biotechnology company earned $0.54 million during the quarter, compared to analysts' expectations of $0.25 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Concert Pharmaceuticals investors own include Intel (INTC), Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Global Blood Therapeutics (GBT), Micron Technology (MU), Pfizer (PFE) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/09/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CNCE
CIK
1367920
Employees
64
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$80.05 million
Net Margins
N/A
Pretax Margin
-300,735.69%
Return on Equity
-109.43%
Return on Assets
-76.65%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.03
Quick Ratio
9.03

Sales & Book Value

Annual Sales
$32.58 million
Price / Sales
12.32
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.24 per share
Price / Book
2.58

Miscellaneous

Outstanding Shares
47,940,000
Free Float
42,507,000
Market Cap
$401.26 million
Optionable
Optionable
Beta
0.52

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:CNCE) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners